Clinical Trial Update: ORal IrON Supplementation With Ferric Maltol in Patients With Heart Failure Carrying Left Ventricular Assist Devices [Phase 4]

View source ↗

Summary

Phase 4 trial update on oral iron supplementation (ferric maltol) in heart failure patients with left ventricular assist devices; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia Iron-deficiency
• Heart Failure

Drugs mentioned

• Ferric Maltol (ferric maltol)

Snippet

Sponsor: Hannover Medical School | Conditions: Heart Failure, Left Sided, Anemia, Iron Deficiency | Phase 4 | Status: TERMINATED